Phase 2 Process: Concept Generation, Design and Evaluation

2021 ◽  
pp. 107-149
Author(s):  
Yongsheng Ma ◽  
Yiming Rong
Keyword(s):  
Phase 2 ◽  
2001 ◽  
Vol 60 (4) ◽  
pp. 215-230 ◽  
Author(s):  
Jean-Léon Beauvois

After having been told they were free to accept or refuse, pupils aged 6–7 and 10–11 (tested individually) were led to agree to taste a soup that looked disgusting (phase 1: initial counter-motivational obligation). Before tasting the soup, they had to state what they thought about it. A week later, they were asked whether they wanted to try out some new needles that had supposedly been invented to make vaccinations less painful. Agreement or refusal to try was noted, along with the size of the needle chosen in case of agreement (phase 2: act generalization). The main findings included (1) a strong dissonance reduction effect in phase 1, especially for the younger children (rationalization), (2) a generalization effect in phase 2 (foot-in-the-door effect), and (3) a facilitatory effect on generalization of internal causal explanations about the initial agreement. The results are discussed in relation to the distinction between rationalization and internalization.


2018 ◽  
Vol 86 (08) ◽  
pp. 456-457
Keyword(s):  
Phase 2 ◽  
Phase 3 ◽  

Die Blockade von Serotoninrezeptoren, insbesondere des Serotonin-Rezeptortyps 5-HT6, als Zusatztherapie in Kombination mit Cholinesterasehemmer, hat in experimentellen Versuchen sowie in einer Phase-2-Studie positive Effekte bei Demenz gezeigt. Im Rahmen eines Phase-3 Entwicklungsprogramms wurde nun die Effektivität des selektiven Serotoninrezeptor-Antagonisten Idalopirdin bei leichter bis mittelschwerer Alzheimer Demenz geprüft.


Pneumologie ◽  
2013 ◽  
Vol 67 (S 01) ◽  
Author(s):  
M Steinmaurer ◽  
N Mürzl ◽  
H Feizelmeier ◽  
J Eckmayr ◽  
V Radulovic
Keyword(s):  

Pneumologie ◽  
2016 ◽  
Vol 70 (S 01) ◽  
Author(s):  
M Steinmaurer ◽  
P Vinatzer ◽  
N Mürzl ◽  
J Eckmayr
Keyword(s):  

Pneumologie ◽  
2016 ◽  
Vol 70 (10) ◽  
Author(s):  
K Olivier ◽  
D Griffith ◽  
K Winthrop ◽  
B Brown-Elliott ◽  
G Eagle ◽  
...  
Keyword(s):  
Phase 2 ◽  

2017 ◽  
Vol 08 (04) ◽  
pp. 188-189
Author(s):  
Katharina Arnheim
Keyword(s):  
Phase 2 ◽  

Auch bei Patienten mit malignem Pleuramesotheliom (MPM) könnte die Immuntherapie künftig für eine verbesserte Prognose sorgen: Erste Daten der noch laufenden Phase-2-Studie MAPS-2 mit Nivolumab und Ipilimumab machen Hoffnung.


Sign in / Sign up

Export Citation Format

Share Document